Prevalence and variation of CHIP in patients with aggressive lymphomas undergoing CD19-directed CAR T-cell treatment
Sign Up to like & getrecommendations! Published in 2022 at "Blood Advances"
DOI: 10.1182/bloodadvances.2021005747
Abstract: Key Points CHIP is frequently observed in patients with r/r lymphoma undergoing CD19-directed CAR T-cell therapy. CHIP does not negatively influence the outcome of CD19-directed CAR T-cell therapy. read more here.
Keywords: cd19 directed; chip; directed car; car cell ... See more keywords